Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2018 1
2019 1
2020 3
2021 3
2022 1
2023 3
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Advanced Stage Head and Neck Cancer Diagnosis: HEADSpAcE Consortium Health Systems Benchmarking Survey.
Creaney G, de Aquino Goulart M, McMahon A, Paterson C, McCaul J, Perdomo S, Mendoza L, Alemany L, Arantes LMR, Urrego PAR, Dudding T, Pring M, Vilensky M, Cuffini C, de Blanc SAL, de Oliveira JC, Pervez S, Saintigny P, Cuello M, Betka J, Pinto LFR, Curado MP, Zendehdel K, Richiardi L, Popovic M, de Podesta JR, von Zeidler SV, Rocha RM; HEADSpAcE Consortium; Alwaheidi S, Brennan P, Virani S, Ross A, Conway DI. Creaney G, et al. Head Neck. 2025 Jul;47(7):1977-1988. doi: 10.1002/hed.28094. Epub 2025 Feb 24. Head Neck. 2025. PMID: 39994901 Free PMC article.
Cross-ancestral GWAS identifies 29 variants across head and neck cancer subsites.
Ebrahimi E, Sangphukieo A, Park HA, Gaborieau V, Ferreiro-Iglesias A, Diergaarde B, Ahrens W, Alemany L, Arantes LM, Betka J, Bratman SV, Canova C, Conlon MS, Conway DI, Cuello M, Curado MP, de Carvalho AC, de Oliviera JC, Gormley M, Hadji M, Hargreaves S, Healy CM, Holcatova I, Hung RJ, Kowalski LP, Lagiou P, Lagiou A, Liu G, Macfarlane GJ, Olshan AF, Perdomo S, Pinto LFR, Podesta JRV, Polesel J, Pring M, Rashidian H, Gama RR, Richiardi L, Robinson M, Rodriguez-Urrego PA, Santi SA, Saunders DP, Soares-Lima SC, Timpson N, Vilensky M, von Zeidler SV, Waterboer T, Zendehdel K, Znaor A, Brennan P; HEADSpAcE Consortium; McKay J, Virani S, Dudding T. Ebrahimi E, et al. Nat Commun. 2025 Oct 2;16(1):8787. doi: 10.1038/s41467-025-63842-z. Nat Commun. 2025. PMID: 41038832 Free PMC article.
Proof of Concept of a Binary Blood Assay for Predicting Radiosensitivity.
Deneuve S, Mirjolet C, Bastogne T, Duclos M, Retif P, Zrounba P, Roux PE, Poupart M, Vogin G, Foray N, Pereira S. Deneuve S, et al. Among authors: roux pe. Cancers (Basel). 2021 May 19;13(10):2477. doi: 10.3390/cancers13102477. Cancers (Basel). 2021. PMID: 34069662 Free PMC article.
Predicting acute severe toxicity for head and neck squamous cell carcinomas by combining dosimetry with a radiosensitivity biomarker: a pilot study.
Deneuve S, Bastogne T, Duclos M, Mirjolet C, Bois P, Bachmann P, Nokovitch L, Roux PE, Girodet D, Poupart M, Zrounba P, Claude L, Ferella L, Iacovelli NA, Foray N, Rancati T, Pereira S. Deneuve S, et al. Among authors: roux pe. Tumori. 2023 Apr;109(2):173-185. doi: 10.1177/03008916221078061. Epub 2022 May 16. Tumori. 2023. PMID: 35578746
High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR.
Assaad S, Avrillon V, Fournier ML, Mastroianni B, Russias B, Swalduz A, Cassier P, Eberst L, Steineur MP, Kazes M, Perol M, Michallet AS, Rey P, Erena-Penet AS, Morel A, Brahmi M, Dufresne A, Tredan O, Chvetzoff G, Fayette J, de la Fouchardiere C, Ray-Coquard I, Bachelot T, Saintigny P, Tabutin M, Dupré A, Nicolas-Virelizier E, Belhabri A, Roux PE, Fuhrmann C, Pilleul F, Basle A, Bouhamama A, Galvez C, Herr AL, Gautier J, Chabaud S, Zrounba P, Perol D, Blay JY. Assaad S, et al. Among authors: roux pe. Eur J Cancer. 2020 Aug;135:251-259. doi: 10.1016/j.ejca.2020.05.028. Epub 2020 Jun 7. Eur J Cancer. 2020. PMID: 32540204 Free PMC article.
Carboplatin in combination with weekly Paclitaxel as first-line therapy in patients with recurrent/metastatic head and neck squamous cell carcinoma unfit to EXTREME schedule.
Pêtre A, Dalban C, Karabajakian A, Neidhardt EM, Roux PE, Poupart M, Deneuve S, Zrounba P, Fayette J. Pêtre A, et al. Among authors: roux pe. Oncotarget. 2018 Apr 24;9(31):22038-22046. doi: 10.18632/oncotarget.25157. eCollection 2018 Apr 24. Oncotarget. 2018. PMID: 29774120 Free PMC article.
12 results